Cell surface trafficking of Fas in NIT-1 cells and dissection of surface and total Fas expression

被引:13
作者
Augstein, P
Dunger, A
Salzsieder, C
Heinke, P
Kubernath, R
Bahr, J
Fischer, U
Rettig, R
Salzsieder, E
机构
[1] Inst Diabet Gerhardt Katsch Karlsburg eV, D-17495 Karlsruhe, Germany
[2] Fachkrankenhaus Orthopadie & Rheumatol, Gommern Vogelsang, Germany
[3] Inselklin, Heringsdorf, Germany
[4] Ernst Moritz Arndt Univ Greifswald, Dept Physiol, Greifswald, Germany
关键词
Fas receptor; beta-cell; apoptose; autoimmune beta-cell destruction; NIT-1; cells; diabetes;
D O I
10.1006/bbrc.2001.6215
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The appearance of Fas receptor at the surface of pancreatic beta-cells affected by progressive insulitis strongly suggests that Fas-mediated beta-cell apoptosis plays an important role in the pathogenesis of type 1 diabetes. In support of this concept, the present study has shown that islet cells from NOD mice and the beta-cell line NIT-1 respond to the proinflammatory cytokines IL-1beta and IFN-gamma with Fas surface expression in a dose and time-dependent manner. Moreover, the prevention of cytokine-induced surface Fas expression by actinomycin D, cycloheximide, and brefeldin A demonstrated that trafficking of Fas to the beta-cell surface requires RNA and protein synthesis and, in addition is critically dependent on intracellular protein transport. Compared with total cellular Fas protein, the amount of Fas at the cell surface was relatively small and indicated that Fas is preferentially expressed in cytoplasmic compartments of NIT-1 cells. It is concluded that inflammatory insults specifically induce translocation of Fas to the beta-cell surface and that interference with cell surface Fas expression is a new strategy to improve beta-cell survival in inflamed islets. (C) 2002 Elsevier Science.
引用
收藏
页码:443 / 451
页数:9
相关论文
共 50 条
  • [31] Rabinovitch A, 1998, DIABETES METAB REV, V14, P129, DOI 10.1002/(SICI)1099-0895(199806)14:2<129::AID-DMR208>3.3.CO
  • [32] 2-M
  • [33] Radfar S, 2000, GASTROEN CLIN BIOL, V24, P1191
  • [34] Scaffidi C, 2000, METHOD ENZYMOL, V322, P363
  • [35] Characterization of Fas (Apo-1, CD95)-Fas ligand interaction
    Schneider, P
    Bodmer, JL
    Holler, N
    Mattmann, C
    Scuderi, P
    Terskikh, A
    Peitsch, MC
    Tschopp, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) : 18827 - 18833
  • [36] Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity
    Schneider, P
    Holler, N
    Bodmer, JL
    Hahne, M
    Frei, K
    Fontana, A
    Tschopp, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (08) : 1205 - 1213
  • [37] Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations
    Siegel, RM
    Frederiksen, JK
    Zacharias, DA
    Chan, FKM
    Johnson, M
    Lynch, D
    Tsien, RY
    Lenardo, MJ
    [J]. SCIENCE, 2000, 288 (5475) : 2354 - 2357
  • [38] Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas
    Sodeman, T
    Bronk, SF
    Roberts, PJ
    Miyoshi, H
    Gores, GJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2000, 278 (06): : G992 - G999
  • [39] Stassi G, 1995, TRANSPLANT P, V27, P3271
  • [40] Nitric oxide primes pancreatic beta cells for fas-mediated destruction in insulin-dependent diabetes mellitus
    Stassi, G
    DeMaria, R
    Trucco, G
    Rudert, W
    Testi, R
    Galluzzo, A
    Giordano, C
    Trucco, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (08) : 1193 - 1200